Fluticasone and salmeterol together are used to treat the symptoms of asthma, including breathing difficulties, wheezing, shortness of breath, coughing, and tightness in the chest. Fluticasone and salmeterol are also used to prevent and treat the symptoms of chronic obstructive pulmonary disease, including as wheezing, shortness of breath, coughing, and chest tightness.
Fluticasone and salmeterol are combined for usage in both adults and children older than 4 years old. Children 12 years of age and older can use fluticasone and salmeterol together.
Fluticasone belongs to the group of drugs known as steroids. It lessens airway edoema, which is how it works. Salmeterol belongs to a group of drugs known as long-acting beta-agonists. It facilitates breathing by calming down and widening airways in the lungs.
Fluticasone and salmeterol are available as a powder and an oral solution for inhalation through a specially crafted inhaler. It is typically utilised twice daily, in the morning and evening, separated by roughly 12 hours. Take salmeterol and fluticasone at around the same times each day.
Ask your doctor or chemist to explain any instructions on your prescription label that you are unsure about following. Salmeterol and fluticasone must be used exactly as prescribed. Use it only as directed by your doctor, neither more nor less often.
Throughout your therapy with salmeterol and fluticasone inhalation, discuss with your doctor how you should take any additional oral or inhaled asthma drugs.
Your doctor would likely advise you to discontinue regularly taking a short-acting beta agonist inhaler like albuterol but to keep using it to treat sudden bouts of asthma symptoms if you were previously doing so. Pay close attention to these guidelines.
Without first consulting your doctor, never alter how you take any of your medications or stop taking any of them. During an asthma or COPD attack, avoid using fluticasone and salmeterol. To use during attacks, your doctor will prescribe a short-acting inhaler.
Inhaling fluticasone and salmeterol reduces the symptoms of some lung disorders but does not treat them. Before you experience the full benefits of fluticasone and salmeterol, it could take a week or longer.
The Global Fluticasone Propionate and Salmeterol Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Two digital maintenance inhalers for asthma sufferers—AirDuo, Digihaler fluticasone propionate and salmeterol and ArmonAir, Digihaler fluticasone propionate—were launched by Teva Pharmaceutical Industries Ltd.
A prescription drug called AirDuo, Digihaler is used to treat and prevent asthma symptoms in persons over the age of 12 including wheezing. For the long-term management of asthma in patients 12 years of age and older, a prescription drug called ArmonAir, Digihaler® is available.
The usage of AirDuo, Digihaler, and ArmonAir, Digihaler® is not intended to treat asthmatic patients’ unexpected breathing issues and does not eliminate the requirement for a rescue inhaler.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.